ANAVEX LIFE SCIENCES CORP. (AVXL) Net income 2016–2025
ANAVEX LIFE SCIENCES CORP. (AVXL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$46.4MFY2025 · since FY2016: -$14.7M → -$46.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$46.4M | -7.8% |
| FY2024 | -$43.0M | +9.5% |
| FY2023 | -$47.5M | +1.0% |
| FY2022 | -$48.0M | -26.6% |
| FY2021 | -$37.9M | -44.2% |
| FY2020 | -$26.3M | +0.1% |
| FY2019 | -$26.3M | -52.4% |
| FY2018 | -$17.3M | -28.2% |
| FY2017 | -$13.5M | +8.7% |
| FY2016 | -$14.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AVXL financial trends
AVXL RevenueAVXL Net marginAVXL Gross profitAVXL Gross marginAVXL Operating incomeAVXL Operating marginAVXL Operating cash flowAVXL Free cash flowAVXL Capital expendituresAVXL Return on equityAVXL Stock buybacksAVXL Dividends paidAVXL Total assetsAVXL Total liabilitiesAVXL Shareholders’ equityAVXL overview →